Advanced Imaging in Cardiac Amyloidosis
- PMID: 35453653
- PMCID: PMC9030502
- DOI: 10.3390/biomedicines10040903
Advanced Imaging in Cardiac Amyloidosis
Abstract
This review serves as a synopsis of multimodality imaging in cardiac amyloidosis (CA), which is a disease characterized by deposition of misfolded protein fragments in the heart. It emphasizes and summarizes the diagnostic possibilities and their prognostic values. In general, echocardiography is the first diagnostic tool in patients with an identified systemic disease or unclear left ventricular hypertrophy. Several echocardiographic parameters will raise suspicion and lead to further testing. Cardiac magnetic resonance and scintigraphy with bone avid radiotracers are crucial for diagnosis of CA and even enable a distinction between different subtypes. The subject is illuminated with established guidelines and innovative recent publications to further improve early diagnosis of cardiac amyloidosis in light of current treatment options.
Keywords: CMR; PET; cardiac amyloidosis; cardiac scintigraphy; echocardiography.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



References
-
- Benson M.D., Buxbaum J.N., Eisenberg D.S., Merlini G., Saraiva M.J.M., Sekijima Y., Sipe J.D., Westermark P. Amyloid nomenclature 2020: Update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid. 2020;27:217–222. doi: 10.1080/13506129.2020.1835263. - DOI - PubMed
-
- Yilmaz A., Kindermann I., Kindermann M., Mahfoud F., Ukena C., Athanasiadis A., Hill S., Mahrholdt H., Voehringer M., Schieber M., et al. Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance. Circulation. 2010;122:900–909. doi: 10.1161/CIRCULATIONAHA.109.924167. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources